Medication adherence in patients with chronic diseases: Significance and new approaches;Medikamentenadhärenz bei chronischen Erkrankungen: Bedeutung und neue Ansätze

Nervenarzt

Volumn 82, Issue 2, 2011, Pages 153-158

  Laufs, U ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Chronic diseases; Medication adherence; Medication compliance; Medication therapy management; Secondary prevention

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; CAREGIVER; CHRONIC DISEASE; HEALTH CARE COST; HUMAN; PATIENT COMPLIANCE; PATIENT COUNSELING; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; GERMANY; HUMANS; MEDICATION ADHERENCE; PREVALENCE; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 79952446515     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-010-3115-4     Document Type: Article

References (48)

1. Düsing R (2006) Therapietreue bei medikamentöser Behandlung. Dtsch Med Wochenschr 131:H28-H30
2. Nöthen M, Böhm K (2009) Krankheitskosten. Robert- Koch-Institut, Berlin
3. Gorenoi V, Schönermark M, Hagen A (2007) Maßnahmen zur Verbesserung der Compliance bzw. Adherence in der Arzneimitteltherapie mit Hinblick auf den Therapieerfolg. DIMDI, Köln
4. Laufs U, Rettig-Ewen V, Böhm M (2010) Strategies to improve drug adherence. Eur Heart J [epub ahead of print]
5. Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119:3028-3035
6. Horne R, Weinman J, Barber N et al (2005) Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO). NCCSDO, London
7. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487-497 (Pubitemid 41127293)
8. Granger BB, Swedberg K, Ekman I et al (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366:2005-2011 (Pubitemid 41773375)
9. Ghali JK, Kadakia S, Cooper R, Ferlinz J (1988) Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 148:2013-2016
10. Bennett SJ, Huster GA, Baker SL et al (1998) Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care 7:168-174 (Pubitemid 128460530)
11. Ambardekar AV, Fonarow GC, Hernandez AF et al (2009) Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). Am Heart J 158:644-652
12. Fonarow GC, Abraham WT, Albert NM et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168:847-854 (Pubitemid 351649267)
13. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296-1310 (Pubitemid 32804122)
14. Gehi AK, Ali S, Na B, Whooley MA (2007) Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 167:1798-1803 (Pubitemid 47403069)
15. Mannesse CK, Derkx FH, Ridder MA de et al (1997) Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 315:1057-1058 (Pubitemid 27458397)
16. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM (1999) Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 55:533-536 (Pubitemid 29446555)
17. Forster AJ, Murff HJ, Peterson JF et al (2005) Adverse drug events occurring following hospital discharge. J Gen Intern Med 20:317-323 (Pubitemid 40617599)
18. Gehi A, Haas D, Pipkin S, Whooley MA (2005) Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 165:2508-2513 (Pubitemid 41720013)
19. Kim MT, Han HR, Hill MN et al (2003) Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med 26:24-31 (Pubitemid 36950987)
20. Rieckmann N, Gerin W, Kronish IM et al (2006) Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 48:2218-2222 (Pubitemid 44855442)
21. Wang PS, Bohn RL, Knight E et al (2002) Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17:504-511 (Pubitemid 34989157)
22. Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22:313-356 (Pubitemid 43003324)
23. WHO (2003) Adherence to long-term therapy: evidence for action. World Health Organization, Geneva
24. Bardel A, Wallander MA, Svardsudd K (2007) Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol 63:307-314 (Pubitemid 46233159)
25. Halling A, Berglund J (2006) Concordance between elderly patients' understanding of and their primary healthcare physician's diagnosis of heart failure. Scand J Prim Health Care 24:110-114
26. Mohammadi M, Ekman I, Schaufelberger M (2009) Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: how come? Vasc Health Risk Manag 5:13-19
27. Charles H, Good CB, Hanusa BH et al (2003) Racial differences in adherence to cardiac medications. J Natl Med Assoc 95:17-27 (Pubitemid 37101972)
28. Gazmararian JA, Kripalani S, Miller MJ et al (2006) Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med 21:1215-1221 (Pubitemid 44665327)
29. Hyre AD, Krousel-Wood MA, Muntner P et al (2007) Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 9:179-186
30. Mochari H, Ferris A, Adigopula S et al (2007) Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol 10:190-195
31. Glader EL, Sjölander M, Eriksson M, Lundberg M (2010) Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 41:397-401
32. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43:521-530 (Pubitemid 40847288)
33. Penning-van Beest FJ, Termorshuizen F, Goettsch WG et al (2007) Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J 28:154-159
34. Rasmussen JN, Chong A, Alter DA (2007) Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297:177-186 (Pubitemid 46089734)
35. Shalev V, Chodick G, Silber H et al (2009) Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med 169:260-268
36. Haynes RB, Ackloo E, Sahota N et al (2008) Interventions for enhancing medication adherence. Cochrane Database Syst Rev CD000011
37. Julius RJ, Novitsky MA Jr, Dubin WR (2009) Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 15:34-44
38. Ogedegbe G, Chaplin W, Schoenthaler A et al (2008) A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens 21:1137-1143
39. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB (2005) Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 39:1198-1203 (Pubitemid 40943169)
40. Düsing R, Handrock R, Klebs S et al (2009) Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens 27:894-901
41. Wu JY, Leung WY, Chang S et al (2006) Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 333:522
42. Paes AH, Bakker A, Soe-Agnie CJ (1997) Impact of dosage frequency on patient compliance. Diabetes Care 20:1512-1517 (Pubitemid 27415025)
43. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH (2007) Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 120:713-719 (Pubitemid 47176510)
44. Reddy KS (2007) The preventive polypill - much promise, insufficient evidence. N Engl J Med 356:212 (Pubitemid 46143223)
45. Gaziano TA, Opie LH, Weinstein MC (2006) Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368:679-686
46. Lee JK, Grace KA, Taylor AJ (2006) Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 296:2563-2571 (Pubitemid 44903860)
47. Bernsten C, Bjorkman I, Caramona M et al (2001) Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 18:63-77 (Pubitemid 32182133)
48. Bates DW, Miller EB, Cullen DJ et al (1999) Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 159:2553-2560